Semaglutide vs tirzepatide: which is right for you?

How they work

Semaglutide and tirzepatide both belong to a class of medications that mimic hormones your body naturally produces after eating. Semaglutide acts on one hormone pathway (GLP-1), which helps regulate appetite and slows how quickly food leaves your stomach, so you feel full sooner and stay full longer.

Tirzepatide goes a step further: it acts on two hormone pathways at once (GLP-1 and GIP). This dual action is why some clinical studies have shown greater average weight loss with tirzepatide, though individual responses vary widely.

Key differences at a glance

Semaglutide

Single pathway (GLP-1) · Once-weekly injection · Longer history of use and research

Tirzepatide

Dual pathway (GLP-1 + GIP) · Once-weekly injection · Newer, with strong recent trial results

What results can you expect?

Results depend on dose, duration, and, most importantly, the lifestyle changes that accompany treatment. Your provider will start you at a low dose and increase it gradually to balance results with comfort.

Side effects and safety

The most common side effects for both medications are digestive, nausea, constipation, or an upset stomach, especially in the first weeks as your body adjusts. These medications aren't right for everyone, which is why every AHBARx plan begins with a physician review of your health history.

How to choose

There's no universally "better" option, there's the option that's better for you. A licensed AHBARx provider can weigh your health history, goals, and preferences to recommend the right starting point.